Learning disorders Mental and Behavioural Disorders
Conditions
Interventions
Participants will be randomised on a one-to-one basis to receive either interpersonal art therapy or be placed on a wait list to receive interpersonal art therapy after they complete their trial parti
Sponsors
Cumbria Northumberland Tyne and Wear NHS Foundation Trust
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 28/02/2024: 1. An inpatient in an NHS secure hospital/unit/service with the presence of learning disability/borderline intellectual functioning indicated by either (a) meeting validated assessment criteria (recognised cognitive testing and adapting functioning assessment), or (b) a score of 57 or below on the Learning Disability Screening Questionnaire (LDSQ) 2. Age 18 to 60 years 3. Able to give informed consent 4. A HONOS (Health of the Nation Outcome Scale) score between 1 and 4 for item 1 (Overactive, aggressive, disruptive, or agitated behaviour / Behavioural problems directed at others) 5. The participants' involvement in the study is supported by their responsible clinician and/or multidisciplinary team (MDT) Previous inclusion criteria: 1. An inpatient in an NHS secure hospital/unit/service with a Learning Disability Screening Questionnaire (LSDQ) score of 57 or below (indicating the presence of learning disability/borderline intellectual functioning/learning difficulty) 2. Age 18 to 60 years (within the age range for the service) 3. Able to give informed consent 4. A score between 1 and 4 on question 1 of the Health of the Nation Outcome Scale Working Age Adult or Learning Disability version (HONOS-WAA or HONOS-LD) 5. The patient’s involvement in the study is supported by their responsible clinician and/or multidisciplinary team (MDT)
Exclusion criteria
Exclusion criteria: Current exclusion criteria as of 28/02/2024: 1. Unable to give informed consent 2. Learning disability/borderline intellectual functioning not indicated based on a validated assessment or screening questionnaire (i.e. not meeting validated assessment criteria or a LDSQ Score >57) 3. A HONOS score of 0 for item 1 4. Planned discharge within 12 months of the start of the study 5. Unstable/unmanaged psychotic symptoms requiring active assessment or treatment including medication dose titration (i.e., dose adjustment in the previous 4 weeks or with potential further dose adjustment planned for the following 4 weeks) Previous exclusion criteria: 1. LDSQ Screening score >57 2. Unable to give informed consent 3. A score of 0 on question 1 of the HONOS-WAA or HONOS-LD 4. Planned discharge within 12 months of the start of the study 5. Receiving active assessment or treatment for acute or unstable/unmanaged psychotic symptoms including medication dose titration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Aggressive behaviour is measured using the Modified Overt Aggression Scale (MOAS) at week 19, weekly between week 19-38, and week 38 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Health Economic analysis will be measured using the EQ5D, the Recovery Quality of Life Scale, and a resource use questionnaire, at baseline, week 19, and week 38 2. Patient distress attributed to psychiatric symptoms is measured using the brief symptom inventory and is measure at week 19 and week 38 | — |
Countries
England, Scotland, United Kingdom
Outcome results
None listed